Figure 3.
Progression in costs for DMTs and other prescription drugs among individuals with MS, during the years after diagnosis with RRMS or PPMS, or conversion to SPMS. Dotted lines indicate 95% confidence intervals. Time since diagnosis = 0 indicates year of MS diagnosis/conversion to SMPS. DMT: disease modifying therapy; RRMS: relapsing–remitting multiple sclerosis; PPMS: primary progressive multiple sclerosis; SEK: Swedish Krona; SPMS: secondary progressive multiple sclerosis.
